Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

74846 Press Releases
DateTitleCompany
10 Dec 12 Truven Health Analytics to Demonstrate Best Practices for Care Improvement at the 24th Annual National Forum on Quality Improvement in Health Care Truven Health Analytics,
Published by
Business Wire
10 Dec 12 The Physicians Foundation Identifies Top Five Issues to Impact Physicians and Patients in 2013 The Physicians Foundation,
Published by
Business Wire
10 Dec 12 Infinity Reports IPI-145 Phase 1 Data Showing Clinical Activity in B-Cell and T-Cell Malignancies at ASH Annual Meeting Infinity Pharmaceuticals Inc.,
Published by
Business Wire
10 Dec 12 Population Diagnostics, Inc. and The Hospital for Sick Children Discover Novel Genetic Variants Associated with Autism Spectrum Disorder Population Diagnostics Inc.,
Published by
Business Wire
10 Dec 12 Seattle Genetics Highlights Next Generation Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting Seattle Genetics Inc.,
Published by
Business Wire
10 Dec 12 Research and Markets: Chinese CRO Company Report - Beijing Genomic Institute (BGI) Research and Markets,
Published by
Business Wire
10 Dec 12 Senesco Provides Summary of SNS01-T Progress in Phase 1b/2a Trial Senesco Technologies Inc.,
Published by
Business Wire
10 Dec 12 Alnylam Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemophilia and Other Bleeding Disorders at 54th American Society of Hematology (ASH) Annual Meeting Alnylam Pharmaceuticals Inc.,
Published by
Business Wire
10 Dec 12 Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in Relapsed Hodgkin Lymphoma and Other CD30-Positive Malignancies from Multiple Presentations at ASH Annual Meeting Seattle Genetics Inc.,
Published by
Business Wire
10 Dec 12 Baxter Presents Phase I/III Data Evaluating Safety and Efficacy of BAX 326, an Investigational Recombinant Factor IX for Hemophilia B, Showing More Than 40 Percent of Patients Experienced No Bleeds Baxter International Inc.,
Published by
Business Wire
10 Dec 12 TetraLogic Pharmaceuticals Announces Presentation on Smac Mimetic Birinapant at American Society of Hematology (ASH) Annual Meeting TetraLogic Pharmaceuticals,
Published by
Business Wire
10 Dec 12 The Ovarian Cancer Drug Market Will More Than Triple Over the Next Decade, Increasing from $460 Million in 2011 to $1.4 Billion in 2021 Decision Resources,
Published by
Business Wire
10 Dec 12 T2 Biosystems Presents Data on Rapid and Direct Hemostasis Monitoring at ASH 2012 T2 Biosystems,
Published by
Business Wire
10 Dec 12 Quintiles CIO Richard Thomas Named a Premier 100 IT Leader by Computerworld Quintiles
10 Dec 12 BrainStorm Deferring Shareholders Conference Call in Anticipation of Upcoming Developments BrainStorm Cell Therapeutics Inc.,
Published by
Business Wire
10 Dec 12 Obagi Medical Confirms Receipt of Directors Nomination Notice from Voce Capital Obagi Medical Products Inc.,
Published by
Business Wire
10 Dec 12 NanoViricides Appoints Project Manager and Engineering Firm for FDA cGMP Plant; Provides Update on anti-Influenza Program NanoViricides Inc.,
Published by
Business Wire
10 Dec 12 DiaTech Test Shows Improved Results for Breast Cancer Patients DiaTech Oncology,
Published by
Business Wire
10 Dec 12 LENSAR Laser System™ Receives FDA Clearance for Corneal Incisions in Cataract Surgery LENSAR Inc.,
Published by
Business Wire
10 Dec 12 Verdezyne Enters into Strategic Relationship with Universal Fiber Systems Verdezyne Inc.,
Published by
Business Wire
10 Dec 12 Eleven Biotherapeutics Initiates Phase 1b Clinical Study of EBI-005, a Novel, Topically-delivered IL-1 Inhibitor Protein for the Treatment of Dry Eye Disease Eleven Biotherapeutics,
Published by
Business Wire
10 Dec 12 Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract Arsenal Medical Inc.,
Published by
Business Wire
10 Dec 12 Bruker Announces Multiple Placements of MALDI Biotyper Systems with Various German Federal, State and Local Governmental Authorities Bruker,
Published by
Business Wire
10 Dec 12 PreCision Dermatology Names Garen Bohlin to Board of Directors PreCision Dermatology Inc.,
Published by
Business Wire
10 Dec 12 Concert Pharmaceuticals Presents Findings Demonstrating Enhanced Potency of CTP-221, a Deuterated S-Enantiomer of Lenalidomide Concert Pharmaceuticals Inc.,
Published by
Business Wire
10 Dec 12 Nexstim Announces Navigated Brain Therapy System, the First Personalized Magnetic Stimulation Solution with CE Mark for Treatment of Depression and Stroke Rehabilitation Nexstim Oy,
Published by
Business Wire
10 Dec 12 Treatment with Pradaxa® associated with better patient outcomes after a major bleeding event compared to warfarin Boehringer Ingelheim,
Published by
Business Wire
10 Dec 12 WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care Worldwide Innovative Network,
Published by
Business Wire
10 Dec 12 Bicycle Therapeutics announces £3.75 million financing for drug discovery Bicycle Therapeutics Limited
10 Dec 12 Bicycle Therapeutics Announces £3.75 Million Financing for Drug Discovery Bicycle Therapeutics,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.